BackTable Urology
@_backtableUro
Followers
4K
Following
2K
Media
262
Statuses
1K
The podcast for all things Urology to help you advance your practice. It's the meeting after the meeting. #UroSoMe #MedEd Visit our website to listen!
Joined August 2020
Behind every smooth intravesical treatment is a clinic team running a tight playbook. Meredith Donahue and Brynn Moore join @RuchikaTalwarMD to discuss practical considerations and nursing-led optimization in NMIBC care @Ferring #URO273
https://t.co/eAu9uNzcbW
0
0
1
Great work @_KochDoc! 🎧👂👏@OSUWexMed
What does it take to save both life and function in a rapidly progressing infection? @jc_hagedorn and @_KochDoc discuss approaches to Fournier’s gangrene, from skin-sparing debridement to early detection and better risk scoring #URO272
https://t.co/3OirBcvrSs
0
4
10
We can do BETTER for Fournier's Gangrene patients! -Spare the skin! -Only cut of DEAD skin. -Leave cellulitis on the patient, EVEN IF THE STUFF BELOW NEEDS TO GO. Here's some tips: https://t.co/RU3UyA1h00 DM me for any questions!
auajournals.org
Great work @_KochDoc! 🎧👂👏@OSUWexMed
1
5
53
@_backtableUro @jc_hagedorn @_KochDoc I am going to try this one day on call will send 📸 @_KochDoc get ready
1
1
5
How do you guide patients through the uncertainty of a new bladder cancer diagnosis? Dr. Sima Porten and Dr. Patrick Hensley join Dr. Vignesh Packiam to discuss patient-centered communication in the diagnosis and early management of non-muscle invasive bladder cancer. They share
0
1
7
What does it take to save both life and function in a rapidly progressing infection? @jc_hagedorn and @_KochDoc discuss approaches to Fournier’s gangrene, from skin-sparing debridement to early detection and better risk scoring #URO272
https://t.co/3OirBcvrSs
1
2
10
Guidelines are helpful, but experience often draws a different line. Dr. Piyush Agarwal and Dr. Anne Schuckman sit down with Dr. Bogdana Schmidt to unpack how they approach newly diagnosed non-muscle invasive bladder cancer (NMIBC). They discuss real-world differences from AUA
0
2
6
Catch our own @_KochDoc 💪👏👇@OSUWexMed
Considering a reconstructive urology fellowship or already navigating one? @You_the_Mann joins @_KochDoc to share her journey in reconstructive urology, covering mentorship, creativity, and growth in a rapidly evolving field #URO270
https://t.co/h0p09dJmn1
0
1
6
Could biomarkers and AI help move bladder cancer care beyond routine cystoscopy? In part five of our NMIBC Creator Weekend™ series, @spsutkaMD @KSMurrayUro and @VigneshPackiam discuss the future of genomics and decision-making in NMIBC @ferring #URO271
https://t.co/rJSXMjhqpm
0
2
11
Multiple people reached out to me because I was mentioned by @You_the_Mann and @_KochDoc on this @_backtableUro podcast. Echoing the message: it's a tremendous privilege to be a reconstructive urologist & help patients through creativity & dedication. @SocietyGURS
Considering a reconstructive urology fellowship or already navigating one? @You_the_Mann joins @_KochDoc to share her journey in reconstructive urology, covering mentorship, creativity, and growth in a rapidly evolving field #URO270
https://t.co/h0p09dJmn1
1
6
31
Considering a reconstructive urology fellowship or already navigating one? @You_the_Mann joins @_KochDoc to share her journey in reconstructive urology, covering mentorship, creativity, and growth in a rapidly evolving field #URO270
https://t.co/h0p09dJmn1
0
4
26
PSA has guided prostate cancer screening for decades—but what’s next? @HafronJason joins @RuchikaTalwarMD to discuss the growing role of biomarkers and AI in prostate cancer care #URO269 @Cleveland_Dx
https://t.co/5kfwD47kXO
0
0
5
The BCG shortage forced the field to adapt in real time - and left behind lessons that could shape the future of bladder cancer care. Dr. Amy Luckenbaugh reflects on key takeaways: the low downside of split dosing, the importance of prioritizing high-risk patients, and the need
0
2
6
Checkpoint inhibitors are changing NMIBC care—and collaboration is key. In the next episode of our NMIBC Creator Weekend, @DrTylerStewart and @BogdanaSchmidt discuss how urologists and medical oncologists are working together to optimize outcomes for bladder cancer patients
0
1
2
New FDA-approved therapies are changing the NMIBC treatment landscape. In Episode 3 of our NMIBC Creator Weekend™ series, @MarkTysonMD @UroBiehn and @BogdanaSchmidt break down where these agents fit in BCG-refractory care @Ferring #URO267
https://t.co/MoYHEPgTSd
@MayoClinic
0
3
9
As more therapies emerge - gem/doce, Adstiladrin, Anktiva, pembrolizumab - patients are increasingly hopeful about alternatives to BCG. Dr. Amy Luckenbaugh highlights the need for clear clinical guidance from professional societies as new evidence accumulates, with thoughtful
0
0
5
🎙️ICYMI: The BackTable Tumor Board team recently hosted a NMIBC Creator Weekend in San Diego! Over the course of the weekend, we recorded eight brand-new episodes covering the latest in NMIBC diagnosis, treatment sequencing, biomarkers, and multidisciplinary care. All 8
0
1
3
How do you tailor NMIBC care to the individual, not just the disease? In Episode 2 of our NMIBC Creator Weekend™ series, @SimaPorten @pjhensley11 and @VigneshPackiam discuss patient-centered approaches in bladder cancer care @Ferring #URO266
https://t.co/yZpMJCneJR
0
2
9
When ischemic priapism strikes, every minute matters. @MaiasaurusRex and @JuanJAndino discuss best practices for diagnosing and managing this urologic emergency #URO265
https://t.co/oZWf08cBXz
@UTSWUrology @UclaUrology @OmerRaheemMD @drhelenbernie @SaveYourSexLife @kingurology
0
7
18